mevastatin has been researched along with Atherogenesis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baumgarten, G; Frede, S; Hilbert, T; Hoeft, A; Klaschik, S; Knuefermann, P; Poth, J | 1 |
Boettger, T; Boon, RA; Braun, T; Dimmeler, S; Frangakis, AS; Hergenreider, E; Heydt, S; Horrevoets, AJ; Mayr, M; Scheffer, MP; Tréguer, K; Urbich, C; Yin, X; Zeiher, AM | 1 |
Dong, J; Fujii, S; Furumoto, T; Goto, D; Imagawa, S; Kitabatake, A; Li, H; Nakabayashi, H; Nishi, S; Sakai, M; Zaman, TA | 1 |
3 other study(ies) available for mevastatin and Atherogenesis
Article | Year |
---|---|
Anti-atherogenic effects of statins: Impact on angiopoietin-2 release from endothelial cells.
Topics: Acyl Coenzyme A; Angiopoietin-2; Atherosclerosis; Cell Survival; Cells, Cultured; Endothelial Cells; Exocytosis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Nitric Oxide; Nitric Oxide Synthase Type III; Pravastatin; Simvastatin; Weibel-Palade Bodies | 2013 |
Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Cells, Cultured; Coculture Techniques; Endothelial Cells; Exosomes; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Kruppel-Like Transcription Factors; Lovastatin; Mice; Mice, Knockout; MicroRNAs; Microscopy, Confocal; Microscopy, Electron; Myocytes, Smooth Muscle; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Stress, Mechanical; Transfection | 2012 |
Interleukin-6 and mevastatin regulate plasminogen activator inhibitor-1 through CCAAT/enhancer-binding protein-delta.
Topics: Animals; Atherosclerosis; Carcinoma, Hepatocellular; CCAAT-Enhancer-Binding Protein-delta; Cell Line, Tumor; Cell Nucleus; Chromosome Mapping; Gene Expression; Hepatocytes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Liver Neoplasms; Lovastatin; Mice; Mice, Inbred ICR; Mutagenesis, Site-Directed; Plasminogen Activator Inhibitor 1; Promoter Regions, Genetic; Response Elements; RNA, Messenger; Thrombosis; Transfection | 2005 |